首页> 外文期刊>Journal of Lipid Research >Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
【24h】

Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.

机译:疏水性增加对A类两亲性螺旋肽的物理化学和生物学特性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

We have recently shown that a class A amphipathic peptide 5F with increased amphipathicity protected mice from diet-induced atherosclerosis (Garber et al. J. Lipid Res. 2001. 42: 545-552). We have now examined the effects of increasing the hydrophobicity of a series of homologous class A amphipathic peptides, including 5F, on physical and functional properties related to atherosclerosis inhibition by systematically replacing existing nonpolar amino acids with phenylalanine. The peptides, based on the sequence Ac-D-W-L-K-A-F-Y-D-K-V-A-E-K-L-K-E-A-F-NH(2) (Ac-18A-NH(2) or 2F) were: 3F(3)(Ac-F(3)18A-NH(2)), 3F(14)(Ac-F(14)18A-NH(2)), 4F(Ac-F(3,14)18A-NH(2)), 5F(Ac-F(11,14,17) 18A-NH(2)), 6F(Ac-F(10,11,14,17)18A-NH(2)), and 7F(Ac-F(3,10,11,14,17) 18A-NH(2)). Measurements of aqueous solubility, HPLC retention time, exclusion pressure for penetration into an egg phosphatidylcholine (EPC) monolayer, and rates of EPC solubilization revealed an abrupt increase in the hydrophobicity between peptides 4F and 5F; this was accompanied by increased ability to associate with phospholipids. The peptides 6F and 7F were less effective, indicating a limit to increased hydrophobicity for promoting lipid interaction in these peptides. Despite this marked increase in lipid affinity, these peptides were less effective than apoA-I in activating the plasma enzyme, lecithin:cholesterol acyltransferase, with 5F activating LCAT the best (80% of apoA-I). Peptides 4F, 5F, and 6F were equally potent in inhibiting LDL-induced monocyte chemotactic activity. These studies suggest that an appropriate balance between peptide-peptide and peptide-lipid interactions is required for optimal biological activity of amphipathic peptides. These studies provide a rationale for the design of small apoA-I-mimetics with increased potency for atherosclerosis inhibition.
机译:最近我们已经显示,具有增加的两亲性的A类两亲性肽5F保护了小鼠免受饮食诱导的动脉粥样硬化(Garber等人,J.Lipid Res.2001.42:545-552)。现在,我们通过系统地用苯丙氨酸替代现有的非极性氨基酸,研究了增加一系列同源的A类两亲肽(包括5F)的疏水性对与动脉粥样硬化抑制相关的物理和功能特性的影响。基于序列Ac-DWLKAFYDKVAEKLKEAF-NH(2)(Ac-18A-NH(2)或2F)的肽为:3F(3)(Ac-F(3)18A-NH(2)),3F( 14)(Ac-F(14)18A-NH(2)),4F(Ac-F(3,14)18A-NH(2)),5F(Ac-F(11,14,17)18A-NH (2)),6F(Ac-F(10,11,14,17)18A-NH(2))和7F(Ac-F(3,10,11,14,17)18A-NH(2) )。测量水溶性,HPLC保留时间,渗透到卵磷脂酰胆碱(EPC)单层中的排阻压力以及EPC增溶的速率表明,肽4F和5F之间的疏水性突然增加。这伴随着与磷脂缔合的能力增强。肽6F和7F效果较差,表明在这些肽中增加疏水性以促进脂质相互作用是有限的。尽管脂质亲和力显着增加,但这些肽在激活血浆酶卵磷脂:胆固醇酰基转移酶方面不如apoA-I有效,其中5F激活LCAT的效果最好(apoA-I的80%)。肽4F,5F和6F在抑制LDL诱导的单核细胞趋化活性方面同样有效。这些研究表明,两亲性肽的最佳生物学活性需要在肽-肽相互作用和肽-脂相互作用之间达到适当的平衡。这些研究为设计小的apoA-I模拟物提供了理论依据,该模拟物具有增强的抑制动脉粥样硬化的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号